Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives
Angiogenesis inhibitor TNP-470: Cytotoxic effects on human neoplastic cell lines
Angiotensin-converting enzymes (ACE and ACE2) are downregulated in renal tumors
Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization
Angiogenic Properties of Natural Rubber Latex Biomembranes and The Serum Fraction of Hevea brasiliensis
Angiogenesis drives psoriasis pathogenesis
Angiogenesis Impairment in Diabetes: Role of Methylglyoxal-Induced Receptor for Advanced Glycation Endproducts, Autophagy and Vascular Endothelial Growth Factor Receptor 2
Angiotensin II Induced MMP-2 Activity and MMP-14 and Basigin Protein Expression Are Mediated via the Angiotensin II Receptor Type 1 Mitogen-Activated Protein Kinase 1 Pathway in Retinal Pigment Epithelium
Angiotensin II-mediated posttranslational modification of nNOS in the PVN of rats with CHF: role for PIN
Angiotensin-(1-7) and Its Effects in the Kidney
Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells
Angiotensin-(1-7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2
Angiotensin-(1-7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats
Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy
Angiotensin II-dependent loss of cardiac function: Mechanisms and pharmacological targets attenuating this effect
Angiotensin II: a regulator of cardiomyocyte function and survival
Angiogenic capacity of M1-and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9
Angiotensin II Type II Receptor Deficiency Accelerates the Development of Nephropathy in Type I Diabetes via Oxidative Stress and ACE2
Angiotensin II Mediates Angiotensin Converting Enzyme Type 2 Internalization and Degradation Through an Angiotensin II Type I Receptor-Dependent Mechanism
Angiogenesis gene expression in mouse uterus during the common pathway of parturition
Angiotensin I-converting enzyme inhibitory activity of protein hydrolysates prepared from three freshwater carps (Catla catla, Labeo rohita and Cirrhinus mrigala) using Flavorzyme
Angiotensin I converting enzyme (ACE) inhibitory peptides from salmon byproduct protein hydrolysate by Alcalase hydrolysis
Angiogenesis and vascular function in the ovary
Angiogenesis in gastric cancer: hitting the target?
Angiogenesis and inflammation in carotid atherosclerosis
Angiotensin-I Converting Enzyme Inhibitory and Antioxidant Activities of Egg Protein Hydrolysates Produced with Gastrointestinal and Nongastrointestinal Enzymes
Angiotensin II-NADPH oxidase-derived superoxide mediates diabetes-attenuated cell excitability of aortic baroreceptor neurons
Angiogenesis and surgery: from mice to man
Angiogenesis
Angiotensin II-induced apoptosis in human endothelial cells is inhibited by adiponectin through restoration of the association between endothelial nitric oxide synthase and heat shock protein 90
Angiopoietin-2, an Angiogenic Regulator, Promotes Initial Growth and Survival of Breast Cancer Metastases to the Lung through the Integrin-linked Kinase (ILK)-AKT-B Cell Lymphoma 2 (Bcl-2) Pathway
Angiopreventive Efficacy of Pure Flavonolignans from Milk Thistle Extract against Prostate Cancer: Targeting VEGF-VEGFR Signaling
Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in Bcl-2 expression
Angiogenesis in ovarian cancer
Angiogenic signaling in Alzheimer's disease
Angiotensin II Increases the Expression of (Pro)Renin Receptor During Low-Salt Conditions
Angiogenesis and melanoma - from basic science to clinical trials
Angiogenic therapy for cardiac repair based on protein delivery systems
Angiogenesis in neurological disorders: a review
Angiographic Regression Patterns After Intravitreal Ranibizumab Injections for Neovascular Age-Related Macular Degeneration
Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles
Angiogenesis and parasitic helminth-associated neovascularization
Angiotensin II revisited: new roles in inflammation, immunology and aging
Angiogenesis as a potential target of pharmaconutrients in cancer therapy
Angiokeratoma: decision-making aid for the diagnosis of Fabry disease
Angiopoietin-like protein 4: health effects, modulating agents and structure-function relationships
Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling
Angiotensin II enhances the afferent arteriolar response to adenosine through increases in cytosolic calcium
Angiographically confirmed stent over expansion in the internal carotid artery during stenting: incidence, predictors, and outcomes
Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant Melanoma
Angiopoietin-2 Promotes Disease Progression of Neuroendocrine Tumors
Angiogenic effects of borate glass microfibers in a rodent model
Angiotensin converting enzyme inhibitors in the treatment of hypertension
Angiopoietin-1 enhances skeletal muscle regeneration in mice
Angiotensin II differentially modulates cyclooxygenase-2, microsomal prostaglandin E-2 synthase-1 and prostaglandin I-2 synthase expression in adventitial fibroblasts exposed to inflammatory stimuli
Angiopoietin-1 but not angiopoietin-2 induces IL-8 synthesis and release by human neutrophils
Angiotensin-(1-7) attenuates the chronotropic response to angiotensin II via stimulation of PTEN in the spontaneously hypertensive rat neurons
Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors
Angiogenesis inhibition for the improvement of photodynamic therapy: The revival of a promising idea
Angiogenesis in liver regeneration and fibrosis: "a double-edged sword"
Angiogenesis: A promising treatment option for peripheral arterial disease
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of reninangiotensinaldosterone system inhibitors involving 158 998 patients
Angiotensin Receptor Blockade Increases Pancreatic Insulin Secretion and Decreases Glucose Intolerance during Glucose Supplementation in a Model of Metabolic Syndrome
Angiotensin II Impairs Glucose Utilization in Obese Zucker Rats by Increasing HPA Activity via an Adrenal-dependent Mechanism
Angiotensin II Regulates Islet Microcirculation and Insulin Secretion in Mice
Angiotensin receptor blockers in the treatment of NASH/NAFLD: Could they be a first-class option?
Angiotensin II type 1 receptor antagonists prevent glucose-induced increases in islet blood flow in rats
Angiotensin II induces superoxide generation via NAD(P)H oxidase activation in isolated rat pancreatic islets
Angiogenic inhibitors for older patients with advanced colorectal cancer: Does the age hold the stage?
Angiogenesis as a therapeutic target in breast cancer
Angiotensin receptors and aging
Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension
Angiotensin AT2 receptor activates the cyclic-AMP signaling pathway in eel
Angiogenic growth factors in maternal and fetal serum in pregnancies complicated with intrauterine growth restriction
Angiogenic growth factors in maternal and fetal serum in concordant and discordant twin pregnancies
Angiogenesis is Regulated by Angiopoietins During Experimental Autoimmune Encephalomyelitis and is Indirectly Related to Vascular Permeability
Angiotensin Converting Enzyme Gene Polymorphism in Turkish Asthmatic Patients
Angiographic Results in Intracranial Aneurysms Treated with Inert Platinum Coils
Angiogenesis in Peritoneal Dialysis
Angiogenesis Markers Quantification in Breast Cancer and Their Correlation with Clinicopathological Prognostic Variables
Angiotensin receptor blockers and myocardial infarction: the importance of dosage
Angiotensin receptor blockers may increase risk of myocardial infarction: Unraveling the ARB-MI paradox
Angiotensin receptor blockers vs. angiotensin converting enzyme inhibitors and acute coronary syndrome outcomes in elderly patients: a population-based cohort study (UMPIRE study results)